Short description
ProUroCare Medical develops devices for the detection and characterization of prostate diseases.
Description
ProUroCare is engaged in the business of developing innovative products for the detection and characterization of prostate disease. Our initial product is a “prostate mechanical imaging” device called the ProUroScan System. The ProUroScan is an imaging system that is designed to produce an elasticity image of the prostate as an adjunctive aid in visualizing and documenting abnormalities of the prostate that have been detected by a digital rectal examination (“DRE”). As an adjunct to DRE, the ProUroScan system will be used following an abnormal DRE to generate real-time images of the prostate that can be stored electronically.
Since our inception, our goal has been to establish the ProUroScan System as the standard of care in the process of detecting and monitoring prostate disease, and to leverage our mechanical imaging technology and intellectual property to create new products both within and outside the field of urology. The key business strategies by which we intend to achieve these objectives include:
Last funding
Absolutely Noaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Eden Prairie, Minnesota, United States, North America
Founded on
January 1, 1999
Exited on
February 29, 2008
Went public on
February 29, 2008
Stock symbol
PUMD
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$7890 - 12340
Sign in for full access